Bobby D. Rush
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
Papers in
-
- Inflammatory mediators and NSAID effects 4
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 3
-
- Gastrointestinal motility and disorders 4
- Co-authors
- Mary J. Ruwart (18 shared papers)M.S. Klepper (6 shared papers)Tiehua Huang (1 shared paper)Michael J. Hageman (1 shared paper)Ping Gao (1 shared paper)William P. Pfund (1 shared paper)Ming‐Shang Kuo (1 shared paper)Walter Morozowich (1 shared paper)
- Journals
- Prostaglandins (6 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Gastroenterology (2 papers)Journal of Pharmaceutical Sciences (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Bobby D. Rush
23 papers receiving 664 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 249
- Gastroenterology 72
- Pharmacology 112
- Pharmacology 97
- Hepatology 41
Countries citing papers authored by Bobby D. Rush
This map shows the geographic impact of Bobby D. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby D. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby D. Rush more than expected).
Fields of papers citing papers by Bobby D. Rush
This network shows the impact of papers produced by Bobby D. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby D. Rush. The network helps show where Bobby D. Rush may publish in the future.
Co-authors
The 25 scholars most cited alongside Bobby D. Rush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 314 | |
| 2 | 1980 | 93 | |
| 3 | 1981 | 77 | |
| 4 | 1979 | 45 | |
| 5 | 1979 | 31 | |
| 6 | 1989 | 30 | |
| 7 | 1978 | 29 | |
| 8 | 1983 | 21 | |
| 9 | 1991 | 13 | |
| 10 | 1985 | 13 | |
| 11 | 1984 | 11 | |
| 12 | 1994 | 10 | |
| 13 | 1966 | 10 | |
| 14 | 1980 | 9 | |
| 15 | 1989 | 8 | |
| 16 | 1984 | 6 | |
| 17 | 1985 | 5 | |
| 18 | 1978 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 1984 | 3 |
About Bobby D. Rush
Bobby D. Rush is a scholar working on Pharmacology, Gastroenterology, Surgery, Pharmacology and Oncology, having authored 23 papers that have together received 739 indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (4 papers), Inflammatory mediators and NSAID effects (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Enhanced Recovery After Surgery (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Pharmaceutical Science (249 citations), Gastroenterology (72 citations), Pharmacology (112 citations), Pharmacology (97 citations) and Hepatology (41 citations). Bobby D. Rush has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Mary J. Ruwart, M.S. Klepper, Tiehua Huang, Michael J. Hageman, Ping Gao, William P. Pfund, Ming‐Shang Kuo, Walter Morozowich, N.M. Friedle and Richard C. Piper. Their work appears in journals such as Prostaglandins, Journal of Pharmacology and Experimental Therapeutics, Gastroenterology, Journal of Pharmaceutical Sciences and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.